Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation

Detalles Bibliográficos
Autores principales: Niscola, Pasquale, Grazia, Carmen Di, Mazzone, Carla, Tolu, Barbara, de Fabritiis, Paolo, Angelucci, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942144/
https://www.ncbi.nlm.nih.gov/pubmed/31915658
http://dx.doi.org/10.5045/br.2019.54.4.288
_version_ 1783484654669529088
author Niscola, Pasquale
Grazia, Carmen Di
Mazzone, Carla
Tolu, Barbara
de Fabritiis, Paolo
Angelucci, Emanuele
author_facet Niscola, Pasquale
Grazia, Carmen Di
Mazzone, Carla
Tolu, Barbara
de Fabritiis, Paolo
Angelucci, Emanuele
author_sort Niscola, Pasquale
collection PubMed
description
format Online
Article
Text
id pubmed-6942144
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-69421442020-01-08 Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation Niscola, Pasquale Grazia, Carmen Di Mazzone, Carla Tolu, Barbara de Fabritiis, Paolo Angelucci, Emanuele Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019-12 2019-12-20 /pmc/articles/PMC6942144/ /pubmed/31915658 http://dx.doi.org/10.5045/br.2019.54.4.288 Text en © 2019 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Niscola, Pasquale
Grazia, Carmen Di
Mazzone, Carla
Tolu, Barbara
de Fabritiis, Paolo
Angelucci, Emanuele
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
title Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
title_full Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
title_fullStr Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
title_full_unstemmed Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
title_short Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
title_sort long-term response in refractory aml following azacitidine-failed mds by salvage decitabine-bridged allogenic transplantation
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942144/
https://www.ncbi.nlm.nih.gov/pubmed/31915658
http://dx.doi.org/10.5045/br.2019.54.4.288
work_keys_str_mv AT niscolapasquale longtermresponseinrefractoryamlfollowingazacitidinefailedmdsbysalvagedecitabinebridgedallogenictransplantation
AT graziacarmendi longtermresponseinrefractoryamlfollowingazacitidinefailedmdsbysalvagedecitabinebridgedallogenictransplantation
AT mazzonecarla longtermresponseinrefractoryamlfollowingazacitidinefailedmdsbysalvagedecitabinebridgedallogenictransplantation
AT tolubarbara longtermresponseinrefractoryamlfollowingazacitidinefailedmdsbysalvagedecitabinebridgedallogenictransplantation
AT defabritiispaolo longtermresponseinrefractoryamlfollowingazacitidinefailedmdsbysalvagedecitabinebridgedallogenictransplantation
AT angelucciemanuele longtermresponseinrefractoryamlfollowingazacitidinefailedmdsbysalvagedecitabinebridgedallogenictransplantation

Ejemplares similares